应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01877 君实生物
未开盘 05-02 16:08:16
12.820
+1.060
+9.01%
最高
12.820
最低
11.420
成交量
90.70万
今开
11.780
昨收
11.760
日振幅
11.90%
总市值
126.37亿
流通市值
28.11亿
总股本
9.86亿
成交额
1,122万
换手率
0.41%
流通股本
2.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
智通AH统计|5月2日
智通财经 · 05-02 16:15
智通AH统计|5月2日
君实生物(01877)上涨5.27%,报12.38元/股
金融界 · 05-02 11:16
君实生物(01877)上涨5.27%,报12.38元/股
君实生物盘中异动 股价大涨5.27%报12.381港元
自选股智能写手 · 05-02 11:16
君实生物盘中异动 股价大涨5.27%报12.381港元
君实生物(688180)3月31日股东户数3.23万户,较上期减少2.07%
证券之星 · 04-30 17:16
君实生物(688180)3月31日股东户数3.23万户,较上期减少2.07%
君实生物董秘回复: 公司在持续提升营业收入的同时,正在加强各项费用管控,优化资源配置
证券之星 · 04-30 17:12
君实生物董秘回复: 公司在持续提升营业收入的同时,正在加强各项费用管控,优化资源配置
君实生物(01877)累计回购78.15万股A股
智通财经 · 04-30 16:44
君实生物(01877)累计回购78.15万股A股
君实生物:累计回购约78万股
每日经济新闻 · 04-30 16:22
君实生物:累计回购约78万股
君实生物04月30日获主力加仓205万元 环比增加1266.67%
自选股智能写手 · 04-30 16:15
君实生物04月30日获主力加仓205万元 环比增加1266.67%
君实生物获太平洋买入评级,适应症扩展成效显著
金融界 · 04-30 15:24
君实生物获太平洋买入评级,适应症扩展成效显著
君实生物午后持续涨超11% 第一季度营收同比增长49.24%
新浪港股 · 04-30 14:21
君实生物午后持续涨超11% 第一季度营收同比增长49.24%
【AH互动】君实生物(01877)AH股午后走高 首季营收同比增长逾49%
金吾财讯 · 04-30 13:59
【AH互动】君实生物(01877)AH股午后走高 首季营收同比增长逾49%
港股异动 | 君实生物(01877)午后涨超6% Q1营收同比增长49.24% 亏损收窄47.92%
智通财经 · 04-30 13:38
港股异动 | 君实生物(01877)午后涨超6% Q1营收同比增长49.24% 亏损收窄47.92%
君实生物(01877)上涨5.17%,报11.4元/股
金融界 · 04-30 13:16
君实生物(01877)上涨5.17%,报11.4元/股
君实生物盘中异动 下午盘急速拉升5.17%
自选股智能写手 · 04-30 13:16
君实生物盘中异动 下午盘急速拉升5.17%
图解君实生物一季报:第一季度单季净利润同比增47.92%
证券之星 · 04-30
图解君实生物一季报:第一季度单季净利润同比增47.92%
君实生物(01877)公布一季度业绩 归母净亏损约2.83亿元 同比收窄47.92%
智通财经网 · 04-29
君实生物(01877)公布一季度业绩 归母净亏损约2.83亿元 同比收窄47.92%
君实生物:2024年第一季度净利润约-2.83亿元
每日经济新闻 · 04-29
君实生物:2024年第一季度净利润约-2.83亿元
君实生物(01877)上涨5.03%,报11.28元/股
金融界 · 04-29
君实生物(01877)上涨5.03%,报11.28元/股
暂无数据
公司概况
公司名称:
君实生物
所属市场:
SEHK
上市日期:
--
主营业务:
上海君实生物医药科技股份有限公司是一家主要从事创新驱动型生物制药业务的中国公司。该公司主要开发创新药物,并全球范围内提供临床研究商业化服务。该公司产品覆盖肿瘤免疫治疗、代谢类疾病、炎症或自身免疫性疾病及神经系统疾病等多个治疗领域。该公司的药品主要用于治疗黑色素瘤、鼻咽癌、食管癌、尿路上皮癌、恶性淋巴瘤等。该公司主要于国内及海外市场提供产品。
发行价格:
--
{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":12.82,"timestamp":1714637296028,"preClose":11.76,"halted":0,"volume":907000,"delay":0,"floatShares":219295700,"shares":985689871,"eps":-2.5154257,"marketStatus":"未开盘","marketStatusCode":0,"change":1.06,"latestTime":"05-02 16:08:16","open":11.78,"high":12.82,"low":11.42,"amount":11216784,"amplitude":0.119048,"askPrice":12.82,"askSize":14400,"bidPrice":12.64,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-2.235433854698183,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714699800000},"adr":0,"listingDate":1545580800000,"adjPreClose":11.76,"openAndCloseTimeList":[[1714613400000,1714622400000],[1714626000000,1714636800000]],"volumeRatio":0.46863886300408886,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物","latestPrice":30.14,"timestamp":1714460400000,"preClose":27.95,"halted":0,"volume":16808864,"delay":0,"premium":"-60.77"}},"requestUrl":"/m/hq/s/01877/tweets","defaultTab":"tweets","newsList":[{"id":"2432562854","title":"智通AH统计|5月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=2432562854","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432562854?lang=zh_cn&edition=full","pubTime":"2024-05-02 16:15","pubTimestamp":1714637705,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止5月2日收盘,东北电气、弘业期货、浙江世宝分列AH溢价率前三位,溢价率分别为988.71%、754.48%、508.17%;招商银行、比亚迪股份、紫金矿业分列AH溢价率末三位,溢价率分别为15.29%、16.32%、21.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116887.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432069082","title":"君实生物(01877)上涨5.27%,报12.38元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432069082","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432069082?lang=zh_cn&edition=full","pubTime":"2024-05-02 11:16","pubTimestamp":1714619797,"startTime":"0","endTime":"0","summary":"5月2日,君实生物(01877)盘中上涨5.27%,截至11:16,报12.38元/股,成交425.92万元。上海君实生物医药科技股份有限公司主要业务是发现、开发和商业化创新疗法,特别是在肿瘤免疫疗法、自身免疫系统疾病、慢性代谢类疾病、神经系统疾病、感染类疾病等治疗方面。公司拥有卓越的创新药物发现能力、先进的生物技术研发、全产业链大规模生产技术和极具市场潜力的在研药品组合。截至2024年一季报,君实生物营业总收入3.81亿元、净利润-2.83亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/02111640509275.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432969769","title":"君实生物盘中异动 股价大涨5.27%报12.381港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432969769","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432969769?lang=zh_cn&edition=full","pubTime":"2024-05-02 11:16","pubTimestamp":1714619791,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘11时16分,君实生物股票出现波动,股价大幅上涨5.27%。截至发稿,该股报12.381港元/股,成交量35.4199万股,换手率0.16%,振幅8.16%。资金方面,该股资金流入239.087万港元,流出173.636万港元。君实生物股票所在的生物技术行业中,整体涨幅为1.00%。该信息摘要如下:君实生物公布2024 年第一季度业绩,营业收入约3.81亿元,同比增长49.24%;归属于上市公司股东的净亏损约2.83亿元,同比收窄47.92%;基本每股亏损0.29元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050211163187e8549d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050211163187e8549d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431833394","title":"君实生物(688180)3月31日股东户数3.23万户,较上期减少2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431833394","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431833394?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:16","pubTimestamp":1714468614,"startTime":"0","endTime":"0","summary":"证券之星消息,近日君实生物披露,截至2024年3月31日公司股东户数为3.23万户,较2月29日减少683.0户,减幅为2.07%。户均持股数量由上期的2.32万股增加至2.37万股,户均持股市值为64.4万元。在生物制品行业个股中,君实生物股东户数低于行业平均水平,截至3月31日,生物制品行业平均股东户数为3.32万户。从股价来看,2024年2月29日至2024年3月31日,君实生物区间跌幅为13.5%,在此期间股东户数减少683.0户,减幅为2.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301723308b65ad17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301723308b65ad17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431391488","title":"君实生物董秘回复: 公司在持续提升营业收入的同时,正在加强各项费用管控,优化资源配置","url":"https://stock-news.laohu8.com/highlight/detail?id=2431391488","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431391488?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:12","pubTimestamp":1714468341,"startTime":"0","endTime":"0","summary":"证券之星消息,君实生物04月30日在投资者关系平台上答复投资者关心的问题。公司在持续提升营业收入的同时,正在加强各项费用管控,优化资源配置,聚焦更有潜力的研发管线,降本增效取得良好成效,2024年第一季度与上年同期相比亏损减少,核心管线亦维持高效推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043017123487c322cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043017123487c322cb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431393126","title":"君实生物(01877)累计回购78.15万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431393126","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431393126?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:44","pubTimestamp":1714466669,"startTime":"0","endTime":"0","summary":"智通财经APP讯,君实生物(01877)发布公告,截至2024年4月30日,公司通过上海证券交易所交易系统以集中竞价交易方式已累计回购股份78.15万股A股,占公司总股本比例为0.0793%,回购成交的最高价为人民币41.69元/股,最低价为人民币29.21元/股,支付的资金总额为人民币2988.32万元(不含印花税、交易佣金等交易费用)。本次回购股份进展符合法律法规的规定及公司回购股份方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116226.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431739824","title":"君实生物:累计回购约78万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431739824","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2431739824?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:22","pubTimestamp":1714465355,"startTime":"0","endTime":"0","summary":"君实生物(SH688180,收盘价:30.14元)4月30日晚间发布公告称,截至2024年4月30日,公司通过上海证券交易所交易系统以集中竞价交易方式已累计回购股份约78万股,占公司总股本比例为0.0793%,回购成交的最高价为人民币41.69元/股,最低价为人民币29.21元/股,支付的资金总额为人民币约2988万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404303065580188.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404303065580188.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431279367","title":"君实生物04月30日获主力加仓205万元 环比增加1266.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431279367","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431279367?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:15","pubTimestamp":1714464924,"startTime":"0","endTime":"0","summary":"04月30日, 君实生物股价涨8.49%,报收11.76元,成交金额4548万元,换手率1.79%,振幅11.07%,量比2.99。君实生物今日主力资金净流入205万元,连续3日净流入,上一交易日主力净流入15万元,今日环比增加1266.67%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为66.67%,平均涨幅为1.09%。该股近5个交易日上涨21.66%,主力资金累计净流入168万元;近20日主力资金累计净流入514万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043016154987c2e337&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043016154987c2e337&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431123365","title":"君实生物获太平洋买入评级,适应症扩展成效显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2431123365","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431123365?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:24","pubTimestamp":1714461899,"startTime":"0","endTime":"0","summary":"4月30日,君实生物获太平洋买入评级,近一个月君实生物获得2份研报关注。研报预计君实生物2024年第一季度营业收入为3.81亿元,同比增长49.24%。预计公司2024/25/26年营业收入分别为21.10亿元、34.42亿元和47.05亿元。研报称赞公司第一季度经营状况,拓益销售收入大幅提升,营业收入的增长主要来源于商业化药品销售的提高。2024年拓益国内医保适应症有望扩至10项,海外商业化也在顺利推进。公司核心管线催化剂亦表现丰富,预计将进一步提升公司的市场竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301525228b65310c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301525228b65310c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431708351","title":"君实生物午后持续涨超11% 第一季度营收同比增长49.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431708351","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2431708351?lang=zh_cn&edition=full","pubTime":"2024-04-30 14:21","pubTimestamp":1714458119,"startTime":"0","endTime":"0","summary":"君实生物(01877)午后持续升高,股价上涨11.26%,现报12.06港元,成交额2973.38万港元。\n 君实生物公布2024年第一季度业绩,营业收入约3.81亿元,同比增长49.24%;归属于上市公司股东的净亏损约2.83亿元,同比收窄47.92%;基本每股亏损0.29元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-30/doc-inatqwyz0589268.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-30/doc-inatqwyz0589268.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431735992","title":"【AH互动】君实生物(01877)AH股午后走高 首季营收同比增长逾49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431735992","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2431735992?lang=zh_cn&edition=full","pubTime":"2024-04-30 13:59","pubTimestamp":1714456741,"startTime":"0","endTime":"0","summary":"金吾财讯 | 君实生物(01877)午后发力走高,截至发稿,报11.58港元,涨6.83%,成交额1950.21万港元。另外,君实生物A股(688180)同步上扬,暂报29.38元人民币,涨4.97%。消息面上,君实生物一季度归属于上市公司股东的净亏损2.83亿元。归属于上市公司股东的扣除非经常性损益的净亏损3.07亿元。基本每股收益-0.29元。期内营收3.81亿元,同比增长49.24%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NTc5ODJhYWQ2MDcxZDU1Zjc2OTIwMzU3MzY2MTU5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NTc5ODJhYWQ2MDcxZDU1Zjc2OTIwMzU3MzY2MTU5Ng==.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1936080","is_publish_highlight":false,"gpt_icon":0},{"id":"2431353127","title":"港股异动 | 君实生物(01877)午后涨超6% Q1营收同比增长49.24% 亏损收窄47.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431353127","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431353127?lang=zh_cn&edition=full","pubTime":"2024-04-30 13:38","pubTimestamp":1714455520,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,君实生物午后涨超6%,截至发稿,涨4.24%,报11.3港元,成交额1414.66万港元。消息面上,君实生物公布2024 年第一季度业绩,营业收入约3.81亿元,同比增长49.24%;归属于上市公司股东的净亏损约2.83亿元,同比收窄47.92%;基本每股亏损0.29元。与此同时,报告期内公司持续加强费用管控,优化资源配置,聚焦更有潜力的研发管线,与上年同期相比亏损减少。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116112.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431633079","title":"君实生物(01877)上涨5.17%,报11.4元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431633079","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431633079?lang=zh_cn&edition=full","pubTime":"2024-04-30 13:16","pubTimestamp":1714454205,"startTime":"0","endTime":"0","summary":"4月30日,君实生物(01877)盘中上涨5.17%,截至13:16,报11.4元/股,成交1085.5万元。上海君实生物医药科技股份有限公司主要业务是发现、开发和商业化创新疗法,特别是在肿瘤免疫疗法、自身免疫系统疾病、慢性代谢类疾病、神经系统疾病、感染类疾病等治疗方面。公司拥有卓越的创新药物发现能力、先进的生物技术研发、全产业链大规模生产技术和极具市场潜力的在研药品组合。截至2024年一季报,君实生物营业总收入3.81亿元、净利润-2.83亿元。4月29日,2024财年一季报归属股东应占溢利-2.83亿人民币,同比增长47.92%,基本每股收益-0.29人民币。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/30131640489135.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431358482","title":"君实生物盘中异动 下午盘急速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431358482","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431358482?lang=zh_cn&edition=full","pubTime":"2024-04-30 13:16","pubTimestamp":1714454205,"startTime":"0","endTime":"0","summary":"2024年04月30日下午盘13时16分,君实生物股票出现异动,股价快速拉升5.17%。君实生物股票所在的生物技术行业中,整体跌幅为0.52%。药品批发,药品委托生产。该信息摘要如下:君实生物公布2024 年第一季度业绩,营业收入约3.81亿元,同比增长49.24%;归属于上市公司股东的净亏损约2.83亿元,同比收窄47.92%;基本每股亏损0.29元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043013164579255ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043013164579255ff8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431681229","title":"图解君实生物一季报:第一季度单季净利润同比增47.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431681229","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431681229?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:00","pubTimestamp":1714413653,"startTime":"0","endTime":"0","summary":"证券之星消息,君实生物2024年一季报显示,公司主营收入3.81亿元,同比上升49.24%;归母净利润-2.83亿元,同比上升47.92%;扣非净利润-3.07亿元,同比上升45.11%;负债率41.63%,投资收益-739.73万元,财务费用-155.26万元,毛利率71.61%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000002716.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431837318","title":"君实生物(01877)公布一季度业绩 归母净亏损约2.83亿元 同比收窄47.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431837318","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2431837318?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:23","pubTimestamp":1714389789,"startTime":"0","endTime":"0","summary":"智通财经APP讯,君实生物(01877)公布2024 年第一季度业绩,营业收入约3.81亿元,同比增长49.24%;归属于上市公司股东的净亏损约2.83亿元,同比收窄47.92%;基本每股亏损0.29元。报告期内,公司营业收入增长主要来自商业化药品销售收入的增长,其中,核心产品特瑞普利单抗注射液(商品名:拓益®/LOQTORZI™,产品代号:JS001)于国内市场实现销售收入约3.07亿元,同比增长约 56.82%。与此同时,报告期内公司持续加强费用管控,优化资源配置,聚焦更有潜力的研发管线,与上年同期相比亏损减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291925078b61cffd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291925078b61cffd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431834704","title":"君实生物:2024年第一季度净利润约-2.83亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431834704","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2431834704?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:02","pubTimestamp":1714388521,"startTime":"0","endTime":"0","summary":"君实生物(SH688180,收盘价:27.95元)4月29日晚间发布一季度业绩公告称,2024年第一季度营收约3.81亿元,同比增加49.24%;归属于上市公司股东的净利润亏损约2.83亿元;基本每股收益亏损0.29元。君实生物的总经理是邹建军,女,53岁,学历背景为博士。截至发稿,君实生物市值为276亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404293063982427.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404293063982427.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431028485","title":"君实生物(01877)上涨5.03%,报11.28元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431028485","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431028485?lang=zh_cn&edition=full","pubTime":"2024-04-29 10:25","pubTimestamp":1714357555,"startTime":"0","endTime":"0","summary":"4月29日,君实生物(01877)盘中上涨5.03%,截至10:25,报11.28元/股,成交585.07万元。上海君实生物医药科技股份有限公司主要业务是发现、开发和商业化创新疗法,特别是在肿瘤免疫疗法、自身免疫系统疾病、慢性代谢类疾病、神经系统疾病、感染类疾病等治疗方面。公司拥有卓越的创新药物发现能力、先进的生物技术研发、全产业链大规模生产技术和极具市场潜力的在研药品组合。截至2023年年报,君实生物营业总收入15.03亿元、净利润-22.82亿元。4月29日,君实生物披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/29102540459762.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.252},{"period":"1month","weight":0.334},{"period":"3month","weight":0.1325},{"period":"6month","weight":-0.3837},{"period":"1year","weight":-0.5698},{"period":"ytd","weight":-0.3405}],"compareEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":0.0753},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0307},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":0.068}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动型生物制药业务的中国公司。该公司主要开发创新药物,并全球范围内提供临床研究商业化服务。该公司产品覆盖肿瘤免疫治疗、代谢类疾病、炎症或自身免疫性疾病及神经系统疾病等多个治疗领域。该公司的药品主要用于治疗黑色素瘤、鼻咽癌、食管癌、尿路上皮癌、恶性淋巴瘤等。该公司主要于国内及海外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.122873},{"month":2,"riseRate":0.833333,"avgChangeRate":0.02917},{"month":3,"riseRate":0.666667,"avgChangeRate":0.049114},{"month":4,"riseRate":0.833333,"avgChangeRate":0.112597},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.027313},{"month":6,"riseRate":0.4,"avgChangeRate":-0.020648},{"month":7,"riseRate":0.4,"avgChangeRate":-0.076121},{"month":8,"riseRate":0,"avgChangeRate":-0.093613},{"month":9,"riseRate":0,"avgChangeRate":-0.097134},{"month":10,"riseRate":0.4,"avgChangeRate":0.053036},{"month":11,"riseRate":0.6,"avgChangeRate":0.067975},{"month":12,"riseRate":0.8,"avgChangeRate":0.175695}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}